Imatikast 400mg Tablet
Marketer
Aprazer Healthcare Pvt Ltd
Salt Composition
Imatinib mesylate (400mg)
Overview Imatikast 400mg Tablet
Imatinib 400mg tablets are indicated for various cancers. Primarily, it's prescribed for hematologic malignancies such as chronic myeloid leukemia and acute lymphoblastic leukemia, along with gastrointestinal stromal tumors. Its mechanism involves targeting proteins crucial for cancer cell proliferation and metastasis. This medication also treats dermatofibrosarcoma protuberans (a skin tumor) and aggressive systemic mastocytosis (a bone marrow disorder). Administer this medication with food, consistently at the same time daily for optimal efficacy. Continue treatment as directed by your physician; duration is individualized based on response and needs. Incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only with your doctor's instruction. Common side effects include edema, nausea, vomiting, muscle spasms, musculoskeletal pain, diarrhea, rash, tiredness, and stomach pain. Report any sudden, significant weight gain. Regular blood count and liver function tests may be recommended. Avoid activities requiring alertness if dizziness or blurred vision occur. Inform your healthcare provider of all other medications, as interactions are possible. This medicine is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout the treatment period.
Uses of Imatikast 400mg Tablet
Oncological Care
Major Benefits of Imatikast 400mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 400mg Imatikast tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
Common Side effects of Imatikast 400mg Tablet:
- Edema (swelling)
- Nausea
- Vomiting
- Muscle cramp
- Musculoskeletal (bone, muscle or joint) pain
- Diarrhea
- Rash
- Fatigue
- Abdominal pain
- Bleeding
- Breathing problems
- Cough
- Weight gain
- Dry eye
- Dizziness
- Hemorrhage
How to use Imatikast 400mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 400mg Imatikast tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.
How Imatikast 400mg Tablet works:
Imatikast 400mg tablets combat cancer by targeting the bcr-abl tyrosine kinase enzyme. This protein drives the uncontrolled growth of cancerous cells. By inhibiting this enzyme, Imatikast halts the proliferation of bcr-abl-positive cancer cells and triggers their programmed self-destruction (apoptosis), thus controlling or slowing cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imatikast 400mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Imatikast 400mg tablets is contraindicated during pregnancy due to established harm to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the risks. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Imatikast 400mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Nursing mothers should discontinue breastfeeding during treatment and for a further 15 days following cessation of Imatikast.
DrivingUNSAFE
Driving ability may be impaired by the use of Imatikast 400mg Tablets, due to potential side effects.
KidneyCAUTION
Patients with kidney impairment should use Imatikast 400mg tablets cautiously, as dose modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Imatikast 400mg tablets cautiously; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Imatikast 400mg Tablet :
Omit any missed Imatikast 400mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Imatikast 400mg Tablet
| Label | Value |
|---|---|
| Pharmaceutical Category | Anilide-based benzamide |
| Potential for Dependence | None. |
| Type of Medication | Cancer-fighting drugs |
| Mechanism of Action | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently